Skip to content
10-K

Annual Report

NEON THERAPEUTICS, INC.

0001694187-19-000026

← back to feed
Filed
Mar 11, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Mar 1, 2019 28.33M sh
Capex FY 2018 · Dec 31, 2017 $3.24M
Capex FY 2018 · Dec 31, 2016 $2.4M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$41.28M
Operating Cash Flow FY 2018 · Dec 31, 2016 −$24.16M
Cash And Equivalents FY 2018 · Dec 31, 2017 $58.25M
Cash And Equivalents FY 2018 · Dec 31, 2016 $88.49M
Current Liabilities FY 2018 · Dec 31, 2017 $8.77M
Total Liabilities FY 2018 · Dec 31, 2017 $8.82M
Current Assets FY 2018 · Dec 31, 2017 $81.31M
Total Assets FY 2018 · Dec 31, 2017 $90.49M
Sga Expense FY 2018 · Dec 31, 2017 $10.89M
Sga Expense FY 2018 · Dec 31, 2016 $7.75M
Rd Expense FY 2018 · Dec 31, 2017 $37.2M
Rd Expense FY 2018 · Dec 31, 2016 $19.67M
Net Income FY 2018 · Dec 31, 2017 −$14.48M
Net Income FY 2018 · Dec 31, 2017 −$47.54M
Net Income FY 2018 · Sep 30, 2017 −$13.99M
Net Income FY 2018 · Jun 30, 2017 −$9.6M
Net Income FY 2018 · Mar 31, 2017 −$9.47M
Net Income FY 2018 · Dec 31, 2016 −$27.43M
Operating Income FY 2018 · Dec 31, 2017 −$48.09M
Operating Income FY 2018 · Dec 31, 2016 −$27.42M
Stockholders Equity FY 2018 · Dec 31, 2016 −$38.49M
Stockholders Equity FY 2018 · Dec 31, 2015 −$9.38M